<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/668E89D7-A623-4683-BE94-DCF2EAF3F347"><gtr:id>668E89D7-A623-4683-BE94-DCF2EAF3F347</gtr:id><gtr:name>Bristol Royal Hospital for Children (BRHC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6A6F7136-FE57-47B4-A357-813B439C03F9"><gtr:id>6A6F7136-FE57-47B4-A357-813B439C03F9</gtr:id><gtr:name>BioMoti</gtr:name><gtr:address><gtr:line1>The QMB Innovation Centre</gtr:line1><gtr:line2>42 New Road</gtr:line2><gtr:postCode>E1 2AX</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/64BC5E73-972F-41E1-A12C-D97DC9BDFB93"><gtr:id>64BC5E73-972F-41E1-A12C-D97DC9BDFB93</gtr:id><gtr:name>MRC Clinical Sciences Centre</gtr:name><gtr:address><gtr:line1>Faculty of Medicine Imperial College</gtr:line1><gtr:line2>London Hammersmith Campus</gtr:line2><gtr:line3>Du Cane Road</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>W12 0NN</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/64BC5E73-972F-41E1-A12C-D97DC9BDFB93"><gtr:id>64BC5E73-972F-41E1-A12C-D97DC9BDFB93</gtr:id><gtr:name>MRC Clinical Sciences Centre</gtr:name><gtr:address><gtr:line1>Faculty of Medicine Imperial College</gtr:line1><gtr:line2>London Hammersmith Campus</gtr:line2><gtr:line3>Du Cane Road</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>W12 0NN</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/668E89D7-A623-4683-BE94-DCF2EAF3F347"><gtr:id>668E89D7-A623-4683-BE94-DCF2EAF3F347</gtr:id><gtr:name>Bristol Royal Hospital for Children (BRHC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6A6F7136-FE57-47B4-A357-813B439C03F9"><gtr:id>6A6F7136-FE57-47B4-A357-813B439C03F9</gtr:id><gtr:name>BioMoti</gtr:name><gtr:address><gtr:line1>The QMB Innovation Centre</gtr:line1><gtr:line2>42 New Road</gtr:line2><gtr:postCode>E1 2AX</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A949BDC6-EAEE-4A45-8018-F8F074341637"><gtr:id>A949BDC6-EAEE-4A45-8018-F8F074341637</gtr:id><gtr:firstName>Kenneth</gtr:firstName><gtr:otherNames>J</gtr:otherNames><gtr:surname>Linton</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U120088463"><gtr:id>936F0419-7986-4FB5-BD09-FB09D2F35503</gtr:id><gtr:title>Membrane Transport Proteins and Disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U120088463</gtr:grantReference><gtr:abstractText>The various organs and tissues of the body are made up of millions of individual cells. The individual cells are enclosed in a fatty sheath called a membrane. Communication between cells, import of nutrients into cells, and export of products and waste products from cells, is dependent on proteins embedded within this fatty sheath. The activity of these proteins is often important in disease. For example, resistance of cancers to chemotherapy, which causes many thousands of premature deaths in the UK, is associated with the membrane protein P-gp. It pumps drugs out of cancer cells and so confers resistance. A second membrane protein, CD36, is known to bind lipids circulating in the blood causing fatty deposits in the arteries which can lead to heart disease. We aim to understand how these proteins work, and how their activities are regulated. This understanding should help us overcome the problem of drug resistance in cancer treatment and help to avoid heart disease.</gtr:abstractText><gtr:technicalSummary>Integral membrane proteins are essential for normal cellular function. They are important components of the plasma membrane controlling influx of nutrients and efflux of metabolites into and out of cells. In all organisms, membrane proteins also transduce signals across the plasma membrane influencing a range of cellular behaviour from motility, metabolism and gene expression to cell division and death. In the full spectrum of human disease, membrane proteins can be both integral to the condition and targets for intervention.||Despite their importance they are often poorly characterised, primarily due to their amphiphilicity and requirement for membrane phospholipids for function. Purification, structure determination and biochemical characterisation therefore remains a challenging problem requiring a multidisciplinary approach. Our group aims to understand the molecular mechanisms of two classes of membrane proteins, ATP Binding Cassette (ABC) transporters and scavenger receptors, using genetic, biochemical, cell biological and structural approaches to fully understand their function in the complex environment of the lipid bilayer and their relationship to disease and treatment.||ABC Transporters are ubiquitous active transporters. The multidrug resistance P-glycoprotein (ABCB1), exports a broad spectrum of compounds many of which are cytotoxic and clinically important as therapeutics. P-glycoprotein is expressed in the gut, liver and kidneys and functions to both limit the uptake and effect the secretion of cytotoxics from the body. When expressed in cancer cells it can also lead to the failure of chemotherapy. Interpretation of biochemical data in light of recent structure determination of a bacterial homologue led us to propose a mechanism for ATP catalysis by P-glycoprotein. Future studies will investigate the nature of the drug binding sites and the precise mechanism coupling these to the ATP catalytic cycle.||In collaboration with clinician Dr Cath Williamson (Institute of Reproductive and Developmental Biology, London) we are also investigating the genetic aetiology of a cholestatic liver disease. ABCB4 is a close relative of P-glycoprotein that is exclusively expressed in the liver where it transports lipids into the bile. We aim to characterise the function of ABCB4 by developing a robust in vitro assay to distinguish between disease-causing and benign mutations and to investigate the influence of environmental and hormonal factors on protein function.||The Class B Scavenger Receptor CD36 is a multi-ligand membrane protein, highly expressed in platelets, macrophages, endothelial cells, adipose tissue, skeletal muscle and heart. Its function is complex and associated with diverse normal physiology (e.g. uptake of long chain fatty acids and oxidised low density lipoproteins (oxLDL)) and several pathological conditions such as atherosclerosis, tumour angiogenesis and cardiomyopathy. We have purified the protein and demonstrated that monomeric CD36 is sufficient to bind oxLDL, however, uptake requires accessory proteins. CD36 is highly modified post translation by glycosylation, palmitoylation and phosphorylation, the functional significance of which is being investigated by mutagenesis. We have established that glycosylation is important for protein folding and that palmitoylation is important for oxLDL uptake, a key step in atherosclerosis. Further characterisation is underway to identify the molecular partners involved in endocytosis of oxLDL.</gtr:technicalSummary><gtr:fund><gtr:end>2009-05-01</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-07-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>855080</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Barts and The London School of Medicine and Dentistry</gtr:department><gtr:description>Barts and the London Charity</gtr:description><gtr:id>E48B4091-C7B7-4122-8080-15DDAF871D4C</gtr:id><gtr:impact>We are currently in the process of recruiting to this post</gtr:impact><gtr:outcomeId>AqFDFPh3jeo-1</gtr:outcomeId><gtr:piContribution>Determination of the effect of ABCB4 mutations on protein function: correlation of the liver disease phenotype with changes in protein function. investigation of reversal of the phenotype.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>BioMoti</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>BioMoti</gtr:description><gtr:id>46DDC5E7-430C-4630-A464-6F663F4EE4B5</gtr:id><gtr:impact>MRC CASE studentship awarded</gtr:impact><gtr:outcomeId>Qr9kHTpT8bC-1</gtr:outcomeId><gtr:partnerContribution>The industrial partner will provide nanoparticles and expertise for use in understanding their uptake into cells.</gtr:partnerContribution><gtr:piContribution>The project involves targeted delivery of nanoparticles to cancer cells. The targeting involves coating the particle with a membrane protein receptor to target a ligand overexpressed on th cancer cell surface. We are actively seeking funding to support investigation of the mechanism of cellular uptake and to optimize drug delivery.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bristol Royal Hospital for Children (BRHC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Bristol Royal Hospital for Sick Children</gtr:description><gtr:id>54A69790-4AA6-46A6-962C-370F93287B5C</gtr:id><gtr:impact>We have submitted a grant application for funding in support of this project.</gtr:impact><gtr:outcomeId>S4jbU4WSLir-1</gtr:outcomeId><gtr:partnerContribution>The team will identify SNPs in drug transporters that are linked with the development of anthracycline-induced cardiomyopathy in children that have been treated for cancer.</gtr:partnerContribution><gtr:piContribution>We will characterize the impact of SNPs on drug efflux transporters identified by the team in Bristol.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Novartis</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Institutes for Biomedical Research</gtr:department><gtr:description>Novartis CASE studentship</gtr:description><gtr:id>2F775380-7080-4413-A461-B7821028F52A</gtr:id><gtr:impact>No outputs as yet. The project is multidisciplinary involving protein biochemistry and biophysical analysis of a clinically relevant receptor.</gtr:impact><gtr:outcomeId>RQDM5wjbnLo-1</gtr:outcomeId><gtr:partnerContribution>Access to antibody generating facilities and Biacore apparatus.</gtr:partnerContribution><gtr:piContribution>We express and purify a membrane to be analysed</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>ABC transporters involved in autocrine signalling in cancer</gtr:description><gtr:id>FD32C15B-783E-4C0D-A948-93BF1687E6EB</gtr:id><gtr:impact>publication 22493979</gtr:impact><gtr:outcomeId>54623f8a48e4c1.90189750-1</gtr:outcomeId><gtr:partnerContribution>demonstrative the activity of this autocrine loop in cancer</gtr:partnerContribution><gtr:piContribution>We have demonstrated that particular ABC transporter secrete autocrine derivatives of membrane lipids</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biological and Chemical Science QMUL</gtr:department><gtr:description>EPR studies</gtr:description><gtr:id>A81A3DB7-A32E-4963-AFCB-EE1CEA62495E</gtr:id><gtr:impact>the collaboration is at an early stage. It is multidisciplinary involving protein biochemistry and biophysics</gtr:impact><gtr:outcomeId>MLc7gEzJFRu-1</gtr:outcomeId><gtr:partnerContribution>access to biophysical analysis of a membrane transport protein</gtr:partnerContribution><gtr:piContribution>we modify, express and purify the transport protein and reconstitute it into nanodiscs for EPR studies by our collaborator</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Centre of the Cell</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BBB35C91-FDFA-4E3F-83E6-BE2B8A10D6F5</gtr:id><gtr:impact>25 pupils in a classroom were engaged on the subject of biology and genetic inheritance

The school already visits the centre of the cell at our Blizard Institute</gtr:impact><gtr:outcomeId>eQkQ8FkZa72</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>950</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Queen Mary university of London Travel Grant</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>Queen Mary University of London</gtr:fundingOrg><gtr:id>FADA7374-8CDB-42D9-9EAD-CE398DBCA2D5</gtr:id><gtr:outcomeId>HwQjXmzJ2M80</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>247000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant Diabetes</gtr:description><gtr:end>2011-03-02</gtr:end><gtr:fundingOrg>Diabetes UK</gtr:fundingOrg><gtr:id>845B6183-5E12-408F-8744-ED312261A8F5</gtr:id><gtr:outcomeId>aQLQmJdo1Qe0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Biochemical society Travel Grant</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>Biochemical Society</gtr:fundingOrg><gtr:id>A53211CF-5633-4225-9825-10E4C3DC41FD</gtr:id><gtr:outcomeId>gGfybhhPaRz0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2012-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>800</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BACR Travel Grant</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>British Association for Cancer Research (BACR)</gtr:fundingOrg><gtr:id>BDCF93A9-0C06-4305-BB54-8F96F5CB1820</gtr:id><gtr:outcomeId>TBsVsDvhGWz0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>950</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Queen Mary university of London Travel Grant</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>Queen Mary University of London</gtr:fundingOrg><gtr:id>DD0EE4FE-D4ED-4284-8DFD-60FB1E2FBABC</gtr:id><gtr:outcomeId>rSyE6h38PBG0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>14000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Pump priming of Interdisciplinary Research</gtr:description><gtr:end>2011-11-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>677C4CF4-6A56-4D0D-B9DB-04942DF6C51D</gtr:id><gtr:outcomeId>NDTpJsFdeeb</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>39000</gtr:amountPounds><gtr:country>Spain, Kingdom of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Spanish ministry of Science Training Fellowship</gtr:description><gtr:end>2009-05-02</gtr:end><gtr:fundingOrg>Spanish Ministry of Science and Innovation</gtr:fundingOrg><gtr:id>07D7FF07-0D20-4CEC-B8B9-78C5D34FF77E</gtr:id><gtr:outcomeId>kHHLGndQD7B0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>128523</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Industrial CASE scheme</gtr:description><gtr:end>2014-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>F1BDDCFC-A8F6-4CDB-B8A0-CF68ACFC1996</gtr:id><gtr:outcomeId>RAKbhGwsq6S0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>105747</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Barts and the London Charity Strategic Research Project Grant</gtr:description><gtr:end>2014-05-02</gtr:end><gtr:fundingOrg>Barts Charity</gtr:fundingOrg><gtr:id>2314F4F1-0AA2-4681-B4A9-9F5BDB664597</gtr:id><gtr:outcomeId>gCuEuXr79nd0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>118927</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Industrial CASE scheme</gtr:description><gtr:end>2018-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>C11D3EA3-A2AB-4EF2-8EAD-866136108448</gtr:id><gtr:outcomeId>54624575912f81.00005759</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>26646</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Additional Sponsorship EPSRC</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>4632A6AC-43CE-4F09-A833-4D5AAA92A8EB</gtr:id><gtr:outcomeId>jR1rTha7dLU</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3292</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Short term fellowship</gtr:description><gtr:end>2011-04-02</gtr:end><gtr:fundingOrg>Federation of European Biochemical Societies (FEBS)</gtr:fundingOrg><gtr:id>428450E7-2590-49A0-AC48-A87DB6DA1E56</gtr:id><gtr:outcomeId>AtWEK9WDdJ50</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>350</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Biochemical society Travel Grant</gtr:description><gtr:end>2014-04-02</gtr:end><gtr:fundingOrg>Biochemical Society</gtr:fundingOrg><gtr:id>DD9714A5-43C6-4464-AA1C-8F7CE474F264</gtr:id><gtr:outcomeId>54634317e722f3.73438264</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel grant</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>Biochemical Society</gtr:fundingOrg><gtr:id>5432EC59-E753-4518-8FFD-FDC0ACD2915E</gtr:id><gtr:outcomeId>J1bJ59mqKVT0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>ABCB4 is a lipid translocase that moves lipid from the hepatocyte into the bile. It is an essential component of the bile and failure to do this causes liver disease. We have shown that ABCB4 can be expressed and studied in cells, but only if another compensatory lipid translocase (which moves a different lipid in the opposite direction) is present.</gtr:description><gtr:id>5C939099-78B2-4941-8C2F-192AE6C9F9D7</gtr:id><gtr:impact>We have demonstrated why bopth of these translocases are necessary for the health of the live.
We have now shown that some mutant ABCB4 that cause liver disease, can be rescued in vitro, with the implication that therapeutic intervention in patients is theoretically possible.</gtr:impact><gtr:outcomeId>ASVXH93jnJn</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Expression system for ABCB4</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:url>http://www.sciencedirect.com/science/article/pii/S0016508511010754</gtr:url><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>575A1463-F2F2-4E99-B85C-229A65F25522</gtr:id><gtr:title>Structure of ABC transporters.</gtr:title><gtr:parentPublicationTitle>Essays in biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33ea58ca27d017dfafb96aaeed7d19d3"><gtr:id>33ea58ca27d017dfafb96aaeed7d19d3</gtr:id><gtr:otherNames>Zolnerciks JK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0071-1365</gtr:issn><gtr:outcomeId>56e05e2cca8b68.60680544</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>004A3D62-E9D2-4FF8-8BCE-CAF53F513142</gtr:id><gtr:title>Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicing.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c5ef3c55e9a78afbed058839c210ae0"><gtr:id>0c5ef3c55e9a78afbed058839c210ae0</gtr:id><gtr:otherNames>Byrne JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>YAnhKJhfMLB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A4F66CE-467B-4849-B918-22B0C0F3DBCB</gtr:id><gtr:title>The multidrug resistance pump ABCB1 is a substrate for the ubiquitin ligase NEDD4-1.</gtr:title><gtr:parentPublicationTitle>Molecular membrane biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6075a928446575ecf5174c021ea42d25"><gtr:id>6075a928446575ecf5174c021ea42d25</gtr:id><gtr:otherNames>Akkaya BG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0968-7688</gtr:issn><gtr:outcomeId>5675e51e4864b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA05E9ED-7D65-47FB-9EF3-848495CC3948</gtr:id><gtr:title>The Q loops of the human multidrug resistance transporter ABCB1 are necessary to couple drug binding to the ATP catalytic cycle.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33ea58ca27d017dfafb96aaeed7d19d3"><gtr:id>33ea58ca27d017dfafb96aaeed7d19d3</gtr:id><gtr:otherNames>Zolnerciks JK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>56e05e2c406669.65415075</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47A882C9-B479-45CB-AA03-937CBBC6EDD2</gtr:id><gtr:title>Inactive alleles of cytochrome P450 2C19 may be positively selected in human evolution.</gtr:title><gtr:parentPublicationTitle>BMC evolutionary biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6cda09f35d3ba99fe9f6c814453a7d0d"><gtr:id>6cda09f35d3ba99fe9f6c814453a7d0d</gtr:id><gtr:otherNames>Janha RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2148</gtr:issn><gtr:outcomeId>54623cfe098360.05469413</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E573E3C7-FDDD-436F-A375-86DFE750098D</gtr:id><gtr:title>Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cee68ceab43a8d2a2500a54c83ab6086"><gtr:id>cee68ceab43a8d2a2500a54c83ab6086</gtr:id><gtr:otherNames>Dixon PH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>56e05e2da8fa08.12789114</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CFDDAF9-19C1-484D-9D7D-83C236A50ABD</gtr:id><gtr:title>Molecular mechanistic explanation for the spectrum of cholestatic disease caused by the S320F variant of ABCB4.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18f7a4ae3c77bc0e7e5aacc31e8764d4"><gtr:id>18f7a4ae3c77bc0e7e5aacc31e8764d4</gtr:id><gtr:otherNames>Andress EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>pm_540e183e18318be97</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>926139FA-646B-4F21-8EB5-36390AECDC99</gtr:id><gtr:title>Cd36, a class B scavenger receptor, functions as a monomer to bind acetylated and oxidized low-density lipoproteins.</gtr:title><gtr:parentPublicationTitle>Protein science : a publication of the Protein Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d6e0097d89bf3442908f49c2495c6a7"><gtr:id>6d6e0097d89bf3442908f49c2495c6a7</gtr:id><gtr:otherNames>Martin CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0961-8368</gtr:issn><gtr:outcomeId>56e05e2dce79a0.74600067</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C05B485-BAA2-45A8-92B3-78B358D77A9C</gtr:id><gtr:title>Evidence for a Sav1866-like architecture for the human multidrug transporter P-glycoprotein.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33ea58ca27d017dfafb96aaeed7d19d3"><gtr:id>33ea58ca27d017dfafb96aaeed7d19d3</gtr:id><gtr:otherNames>Zolnerciks JK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>56e05e2d5609c4.44227172</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1561164-6832-407A-98AA-39652868CE61</gtr:id><gtr:title>ABCB4 missense mutations D243A, K435T, G535D, I490T, R545C, and S978P significantly impair the lipid floppase and likely predispose to secondary pathologies in the human population.</gtr:title><gtr:parentPublicationTitle>Cellular and molecular life sciences : CMLS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18f7a4ae3c77bc0e7e5aacc31e8764d4"><gtr:id>18f7a4ae3c77bc0e7e5aacc31e8764d4</gtr:id><gtr:otherNames>Andress EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1420-682X</gtr:issn><gtr:outcomeId>58b561ecb33ad3.77469397</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18563570-D2CA-43EE-81E2-4FB968438333</gtr:id><gtr:title>Lipid flopping in the liver.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad9e02bff369efce03660858f8e0be2a"><gtr:id>ad9e02bff369efce03660858f8e0be2a</gtr:id><gtr:otherNames>Linton KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>56e05e2c0f5a90.75820865</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD218C25-99E4-4536-9A29-A3CA77674F83</gtr:id><gtr:title>Structure and function of ABC transporters.</gtr:title><gtr:parentPublicationTitle>Physiology (Bethesda, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad9e02bff369efce03660858f8e0be2a"><gtr:id>ad9e02bff369efce03660858f8e0be2a</gtr:id><gtr:otherNames>Linton KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1548-9221</gtr:issn><gtr:outcomeId>56e05e2e0b5161.89172040</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F04AEAC2-0F64-42AC-B978-6A4F9B4158FD</gtr:id><gtr:title>Complementary functions of the flippase ATP8B1 and the floppase ABCB4 in maintaining canalicular membrane integrity.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/430de9052e182a244cdb6d569c83b8bf"><gtr:id>430de9052e182a244cdb6d569c83b8bf</gtr:id><gtr:otherNames>Groen A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>56e05e2c6e9929.54193850</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A01F495A-915B-486A-85AE-9D50D4F13E65</gtr:id><gtr:title>Structure and function of ABC transporters: the ATP switch provides flexible control.</gtr:title><gtr:parentPublicationTitle>Pflugers Archiv : European journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad9e02bff369efce03660858f8e0be2a"><gtr:id>ad9e02bff369efce03660858f8e0be2a</gtr:id><gtr:otherNames>Linton KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0031-6768</gtr:issn><gtr:outcomeId>56e05e2d822c98.78682429</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>071ACBE1-72DB-408D-8398-D428D2CB9A3E</gtr:id><gtr:title>The ABC transporters of human physiology and disease</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad9e02bff369efce03660858f8e0be2a"><gtr:id>ad9e02bff369efce03660858f8e0be2a</gtr:id><gtr:otherNames>Linton KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:isbn>978-981-4280-06-8</gtr:isbn><gtr:outcomeId>5463a27c49f8f2.89200200</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DFE97F6-4C83-46F0-BE2D-FA2BB62EC8A2</gtr:id><gtr:title>The Human Scavenger Receptor CD36: glycosylation status and its role in trafficking and function.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95a11d9bd84ac1aec1e668a14e21d6b5"><gtr:id>95a11d9bd84ac1aec1e668a14e21d6b5</gtr:id><gtr:otherNames>Hoosdally SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>56e05e2cf15a31.38084593</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F4D0FF2-16EF-481C-B926-3C10CDA30D12</gtr:id><gtr:title>Mutations in AQP5, encoding a water-channel protein, cause autosomal-dominant diffuse nonepidermolytic palmoplantar keratoderma.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6cb0132e63f15da395f14e2f5217726"><gtr:id>a6cb0132e63f15da395f14e2f5217726</gtr:id><gtr:otherNames>Blaydon DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_14917_27_23830519</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC3B752E-8801-4DB3-8008-DD615140B481</gtr:id><gtr:title>Canalicular ABC transporters and liver disease.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/939cacce23215069c7d1f76270ca6e7b"><gtr:id>939cacce23215069c7d1f76270ca6e7b</gtr:id><gtr:otherNames>Nicolaou M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>56e05e2ca04226.89223329</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ECBBED78-A7BD-4BD1-A83A-66E6F38E4A6D</gtr:id><gtr:title>Investigational ABC transporter inhibitors.</gtr:title><gtr:parentPublicationTitle>Expert opinion on investigational drugs</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b24adb473afaa002d8330efecd4e1a84"><gtr:id>b24adb473afaa002d8330efecd4e1a84</gtr:id><gtr:otherNames>Falasca M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1354-3784</gtr:issn><gtr:outcomeId>pm_14917_27_22493979</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U120088463</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>67</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>67</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>